Inter Pharma PCL (BKK:IP)

Market Cap	2.37B +78.2%
Revenue (ttm)	2.21B +15.8%
Net Income	122.38M +233.9%
EPS	0.20 +233.9%
Shares Out	605.34M
PE Ratio	19.39
Forward PE	n/a
Dividend	0.07 (1.86%)
Ex-Dividend Date	May 6, 2026

Volume	271,930
Average Volume	482,174
Open	3.880
Previous Close	3.900
Day's Range	3.840 - 4.040
52-Week Range	2.960 - 4.700
Beta	0.47
RSI	35.83
Earnings Date	Feb 27, 2026

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes drug and dietary supplement products for humans and animals in Thailand. It operates through three segments: Human healthcare, Animal healthcare, and Hospital and clinics. The company offers healthcare, anti-aging, and human beauty products, such as medical supplies, nutrition therapy, cosmetics, supplementary food, probiotic and prebiotic products, health and general food products, pharmaceuticals and cosmeceuticals products, functional food and drinks, and medical equi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2025, Inter Pharma PCL's revenue was 2.21 billion, an increase of 15.80% compared to the previous year's 1.91 billion. Earnings were 122.38 million, an increase of 233.93%.